• Nenhum resultado encontrado

ESR1 Gene Polymorphisms and Prostate Cancer Risk: A HuGE Review and Meta-Analysis.

N/A
N/A
Protected

Academic year: 2017

Share "ESR1 Gene Polymorphisms and Prostate Cancer Risk: A HuGE Review and Meta-Analysis."

Copied!
12
0
0

Texto

Loading

Imagem

Figure 1. Flow chart of literature search and study selection.
Table 1. Characteristics of included studies in this meta-analysis.
Figure 2. Subgroup analysis by ethnicity of ORs with a random-effects model for associations between ESR1 PvuII (C.T) polymorphism and prostate cancer risk under dominant model (TT + TC vs
Table 2. Meta-analysis of the association between ESR1 PvuII (C.T) polymorphism and prostate cancer risk.
+3

Referências

Documentos relacionados

This meta-analysis suggests that the polymorphism rs198977 of KLK2 was associated with susceptibility of prostate cancer in Caucasian and the allele T might increase the risk

Objective: To evaluate the influence of polymorphisms in GSTA1, GSTM1, GSTT1, and GSTP1 in the risk of developing Prostate Cancer (PCa) in a population of Rio de Janeiro and

The previous meta- -analysis showed the hOGG1 gene polymorphism increases the occurrence of bladder cancer for most all non-smokers (16), but our result point this risk only be

Recently, a case-control study found that the IL-22 -429 C/T gene polymorphism might be associated with the risk and multifocality of papillary thyroid cancer (26).. In 561 colon

Association of folate-pathway gene polymorphisms with the risk of prostate cancer: a population-based nested case-control study, systematic review, and meta- analysis.. Cancer

In the present study, the association between CYP1A1 gene polymorphisms (IVS1-728G > A, Thr461Asn and Ile462Val), and the risk of oral cancer, was examined among 157 patients

tween MTR A2756G polymorphism and the risk for head and neck cancer and a higher frequency of carriers of the G allele variant in men with head and neck cancer

Analysis of the change (%) in overall, breast and prostate cancer crude mortality rate (deaths per 100,000) attributable to demographic and risk factors for the population of